Registration open for BME 713S: Frontiers in Biodesign Seminar – Spring 2024

Dear Duke Community,

We are excited to inform you that the BME 713S: Frontiers in Biodesign seminar series will be offered again for the Spring 2024 semester. This engaging and informative course will take place on Fridays in Wilkinson Auditorium from 3:00 pm to 4:00 pm.

Drs. Daniel Reker and Lingchong You will be the instructors for this semester’s course. Their expertise and passion for the subject promise a rewarding and insightful learning experience for all participants.

Trainees are strongly encouraged to sign up, and registration is now open in Duke Hub for the Spring 2024 semester. Please secure your spot at your earliest convenience, as we have a limited number of open seats (30).

For a preview of the exciting lineup of speakers scheduled for the seminar series, please visit our Center for Quantitative Biodesign website. We have curated a diverse and distinguished group of speakers who will share their insights and experiences in the field.

For any questions, please contact our Program Coordinator, Xavier Larkin at xavier.larkin@duke.edu or the Center’s email address at dukeqbiodesigncenter@gmail.com

Facilitating Nirmatrelvir Clinical Development with Quantitative Systems Pharmacology with Dr. Richard Allen | December 1, 2023| Pfizer

On behalf of the Duke Center for Quantitative Biodesign, we would like to send a special thank you to Dr. Richard Allen, Research Fellow at Pfizer, for his insightful presentation on “Facilitating Nirmatrelvir Clinical Development with Quantitative Systems Pharmacology” last Friday, 12/1.

We also appreciate your time meeting with trainees and additional faculty members. Your contributions were invaluable.

Dr. Lingchong You- Faculty Host introducing guest speaker, Dr. Richard Allen
Lunch with trainees from the You Lab.
Meeting with Dr. Daniel Reker departing Wilkinson Building

CQB Seminar: Dr. Richard Allen

Our next guest speaker will be Dr. Richard Allen. Dr. Allen is a Research Fellow at Pfizer, where he leads QSP efforts in Anti-infectives, Inflammation and Immunology, and Internal Medicine. He has a PhD in Applied Mathematics from University College London. He joined Pfizer in 2012 following a Postdoctoral position at University of North Carolina. His research interests include novel methods for building virtual populations for QSP models.

Abstract: Quantitative Systems Pharmacology (QSP) is the application of mathematical models of physiology and disease to simulate the existing and novel pharmacological treatments. In this talk I will briefly introduce QSP and discuss its application to Covid-19 therapies. Beyond discussing the technical approaches and challenges, I will also touch upon industry careers and some of the differences in using modeling to address questions in industry in comparison to academia.

Save the Date: Dr. Hyun Youk | November 17, 2023| UMass Chan Medical School

Our next guest speaker for this semester will be, Dr. Hyun Youk, an Associate Professor of Systems Biology at UMass Chan Medical School. He received his B.S. in Physics and Mathematics from the University of Toronto, his M.A. in Astronomy and Physics from Johns Hopkins University, and his Ph.D. in Physics from Massachusetts Institute of Technology. His lab began in January 2015 at the Kavli Institute of Nanoscience in Delft, the Netherlands. After nearly six years, he moved to the University of Massachusetts Medical School (UMass Med).

His passion in life is understanding what it means to “live” and “die.” Is death inevitable? If so, why is that? If not, what are we and all other organisms doing wrong? In our attempt to address these questions, our lab seeks quantitative principles that dictate the dynamics of cellular systems. These systems include cell-signaling circuits, populations of interacting cells, and organisms that appear to be “dead” but are, in fact, merely at the nexus of life and death (e.g., dormant yeast spores).

Abstract:

One of the hallmarks of a living cell is that it can replicate itself. An important question is when and why a cell might permanently lose its ability to proliferate and thereby transition into being a dead cell. The design principles that govern such “life-to-death” transition remain incompletely understood. In this talk, he will describe two experimental studies in which we used the budding yeast, S. cerevisiae, to reveal such design principles in the context of high and frigid temperatures. Temperature is a universal parameter for life in that it controls the speed of all biochemical reactions in all organisms and every habitat.

By either increasing the temperature to sufficiently high values or decreasing the temperature to sufficiently low values, we placed yeast cells at the (apparent) edge of their capacity to duplicate. For both high temperatures (> 38 C) and near-freezing temperatures (0 C – 5 C), we found ways to extend yeast’s ability to duplicate: we could enable more cells to duplicate with drastically shortened doubling times. We constructed “phase diagrams” that describe cell-population growths for both temperature regimes.

The same mathematical model, with one free parameter, reproduced both phase diagrams as well as stochastic proliferation of individual cells. At near-freezing temperatures, we discovered “speed limits” – slowest and fastest possible doubling times – at which a yeast cell’s life can progress: a cell that progresses more slowly than a “low-speed limit” defined for each temperature faces a certain death. A mathematical model and experimental data elucidated how these speed limits arise. These findings establish a quantitative foundation for engineering organisms that can survive extreme temperatures and elucidating fundamental limits to slowing down life.

 

Upcoming Speaker- Dr. Adam Gormley | November 3, 2023 | Rutgers University

Our next guest speaker will be Dr. Adam Gormley on Friday, November 3, 2023 at 3:00 pm in Wilkinson 132. Dr. Gormley is an Associate Professor of Biomedical Engineering at Rutgers University and an expert in nanobiomaterials. Prior to Rutgers, Adam was a Marie Skłodowska-Curie Research Fellow at the Karolinska Institutet (2016) and a Whitaker International Scholar at Imperial College London (2012-2015) in the laboratory of Professor Molly Stevens. He obtained his PhD in Bioengineering from the University of Utah in the laboratory of Professor Hamid Ghandehari (2012), and a BS in Mechanical Engineering from Lehigh University (2006). In January 2017, Adam started the Gormley Lab which seeks to develop bioactive nanobiomaterials using robotics and artificial intelligence. Dr. Gormley is currently the PI of an NIH R35 MIRA Award, an NSF CBET Award, and an NSF Designing Materials to Revolutionize and Engineer our Future (DMREF) Award. He was recently named a Rising Star by Advanced Healthcare Materials, is the recipient of the A. Walter Tyson Assistant Professorship, the Young Innovator Award by Cellular and Molecular Bioengineering, and the Presidential Fellowship for Teaching Excellence.

Gormley’s abstract: The seamless integration of synthetic materials with biological systems long remains a grand challenge, often curtailed by the sheer complexity of the cell-material interface. For decades, biomaterial scientists and engineers have designed around this complexity by rationally designing new materials one experiment at a time. However, recent advances in laboratory automation, high throughput analytics, and artificial intelligence / machine learning (AI/ML) now provide a unique opportunity to fully automate the design process. In this seminar, we put forth our efforts to develop a biomaterials acceleration platform (BioMAP) (i.e., self-driving biomaterials lab) that can rapidly iterate through design spaces and identify unique material properties that perfectly synergize with biological complexity.

2nd Annual Biomolecular Condensates Symposium- October 16-17, 2023

ICYMI: On behalf of the Duke Center for Quantitative Biodesign, we thank all attendees, invited speakers, faculty, and staff for making the 2nd Annual Biomolecular Condensates Symposium during Fall Break a success. Your expertise and participation are greatly appreciated. We are already looking forward to next year’s symposium.

Registration
Poster Session
Session II: Amy Gladfelter, Duke University (left)and (right) Edward Lemeke, Johannes Gutenburg University Mainz presenting: “Decoding Molecular Plasticity in the Dark Proteome.”

In Memoriam: Remembering Dr. Philip Benfey

Philip Benfey, ph.d.

INVESTIGATOR OF THE HOWARD HUGHES MEDICAL INSTITUTE AND THE PAUL KRAMER PROFESSOR OF BIOLOGY

The Duke Center for Quantitative Biodesign mourns the loss of our esteemed colleague, Dr. Philip Benfey, an investigator of the Howard Hughes Medical Institute and the Paul Kramer Professor of Biology. Dr. Benfey was a distinguished scientist, known for his pioneering work in genetics, molecular biology, and mathematical modeling. His groundbreaking research on cellular identity and root development in Arabidopsis thaliana was truly transformative.

Dr. Benfey’s ability to bridge theory and practice was exemplified by his founding of three companies—GrassRoots Biotechnology, Hi Fidelity Technologies, and Ground Control Robotics. He was recognized as a fellow of the American Association for the Advancement of Science and a member of the US National Academy of Sciences.

Beyond his scientific achievements, Dr. Benfey was a warm-hearted mentor and friend who inspired all who knew him. His legacy will continue to inspire future generations of scientists.

Our deepest condolences to Dr. Benfey’s family, students, friends, and colleagues. His memory will forever guide us in our pursuit of scientific excellence.

https://today.duke.edu/2023/10/duke-flags-lowered-philip-benfey-plant-biologist-who-studied-roots-window-development-dies